G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
G1 Therapeutics (GTHX) Misses Q3 EPS by 1c; Offers FY23 COSELA Sales Guidance
November 1, 2023 6:33 AM EDTG1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $14.24 million.
The Company expects to generate between $44 million and $47 million in COSELA net revenue in... More
